Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Alliance Grants

McGill University

$25,000.00

Evolution and mechanics of plant transporters moving medicinal cargo

FY 2024-25

Summary
Plant natural products offer a deep reservoir of bioactive metabolites that are valuable for health and agriculture. One bright example is Catharanthus roseus (Madagascar periwinkle), known for the anticancer drugs vincristine and vinblastine. This plant employs a complex compartmentalization for the biosynthesis of these drugs that involves inter- and intra-cellular trafficking of the intermediates. Understanding the players in this transport can allow us to recreate the plant pathway in engineered microbes better suited for the sustainable and scalable production of high-value anticancer drugs. We recently characterized CrMATE1 as a vacuolar importer of secologanin - a vital metabolic intermediate in the biosynthesis of anticancer compounds. Challenges: We require a robust and pristine spherical membrane (vesicle) to assay this transporter for the "mechanics" of transport, i.e., kinetics, substrate range, and pH dependence. We want to trace the "evolution" of such a unique transporter by looking at related species in the plant family (Apocynaceae). Approach: We propose using a liposome (small artificial lipid vesicle) system for the functional analysis of CrMATE1 and related plant MATEs. Thereby, we can bypass the complexity of plant cells and look at our transporters in isolation to ascertain their mechanics and evolution. The liposome system is the gold standard of transporter research and has not been applied to plan studies. Opportunities: This project and collaboration with the Mulligan lab (University of Kent, UK), a global leader in transporter characterization, will help develop the liposome system. The synergy of our expertise in plant biochemistry and their deep knowledge of the tool will allow a novel foray into this area. Including MATE transporters in engineered microbes can increase the yield of high-value compounds. This represents a significant opportunity for Canada to stake a claim in developing tools and intellectual property in the microbial supply chain for anticancer drugs. Trainees on this project will be capable of developing the liposome-based approach in my lab and training other HQP at the Center for Structural Biology at McGill University.
Program
Alliance Grants
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
597729-2024
Name nom
Dastmalchi, Mehran M
Department département
Agricultural and Environmental Sciences, Faculty of
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
25000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5400
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Biochemistry
Research subject fr
Biochimie
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Evolution and mechanics of plant transporters moving medicinal cargo
Keywords
apocynaceae; biochemistry; catharanthus roseus; cellular transport; liposomes; monoterpenoid indole alkaloids; multidrug & toxic compound extrusion; plant metabolism; secologanin; transporters
Application summary
Plant natural products offer a deep reservoir of bioactive metabolites that are valuable for health and agriculture. One bright example is Catharanthus roseus (Madagascar periwinkle), known for the anticancer drugs vincristine and vinblastine. This plant employs a complex compartmentalization for the biosynthesis of these drugs that involves inter- and intra-cellular trafficking of the intermediates. Understanding the players in this transport can allow us to recreate the plant pathway in engineered microbes better suited for the sustainable and scalable production of high-value anticancer drugs. We recently characterized CrMATE1 as a vacuolar importer of secologanin - a vital metabolic intermediate in the biosynthesis of anticancer compounds. Challenges: We require a robust and pristine spherical membrane (vesicle) to assay this transporter for the "mechanics" of transport, i.e., kinetics, substrate range, and pH dependence. We want to trace the "evolution" of such a unique transporter by looking at related species in the plant family (Apocynaceae). Approach: We propose using a liposome (small artificial lipid vesicle) system for the functional analysis of CrMATE1 and related plant MATEs. Thereby, we can bypass the complexity of plant cells and look at our transporters in isolation to ascertain their mechanics and evolution. The liposome system is the gold standard of transporter research and has not been applied to plan studies. Opportunities: This project and collaboration with the Mulligan lab (University of Kent, UK), a global leader in transporter characterization, will help develop the liposome system. The synergy of our expertise in plant biochemistry and their deep knowledge of the tool will allow a novel foray into this area. Including MATE transporters in engineered microbes can increase the yield of high-value compounds. This represents a significant opportunity for Canada to stake a claim in developing tools and intellectual property in the microbial supply chain for anticancer drugs. Trainees on this project will be capable of developing the liposome-based approach in my lab and training other HQP at the Center for Structural Biology at McGill University.